<code id='CCC1768376'></code><style id='CCC1768376'></style>
    • <acronym id='CCC1768376'></acronym>
      <center id='CCC1768376'><center id='CCC1768376'><tfoot id='CCC1768376'></tfoot></center><abbr id='CCC1768376'><dir id='CCC1768376'><tfoot id='CCC1768376'></tfoot><noframes id='CCC1768376'>

    • <optgroup id='CCC1768376'><strike id='CCC1768376'><sup id='CCC1768376'></sup></strike><code id='CCC1768376'></code></optgroup>
        1. <b id='CCC1768376'><label id='CCC1768376'><select id='CCC1768376'><dt id='CCC1768376'><span id='CCC1768376'></span></dt></select></label></b><u id='CCC1768376'></u>
          <i id='CCC1768376'><strike id='CCC1768376'><tt id='CCC1768376'><pre id='CCC1768376'></pre></tt></strike></i>

          fashion

          fashion

          author:leisure time    Page View:737
          Frank Pallone -- health policy coverage from STAT
          Rep. Frank Pallone (D-N.J.) J. Scott Applewhite/AP

          WASHINGTON — A Democrat has signed on to a legislative package that would require health care transparency by law and enact modest payment reforms to pharmacy middlemen and hospitals, increasing its chances of passing the House of Representatives.

          Republicans conceded to a few tweaks to the legislation to ensure that transparency regulations for hospitals were at least equal to current regulations, which gained the endorsement of House Energy and Commerce Committee ranking member Frank Pallone (D-N.J.).

          advertisement

          Two other prominent Democrats on relevant committees didn’t sign on: Rep. Richard Neal (D-Mass.), who had voiced concerns about the bill’s lack of transparency provisions requiring disclosure of private equity ownership, and Rep. Bobby Scott (D-Va.).

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Was Amgen transparent enough on FDA's concern on cancer drug?
          Was Amgen transparent enough on FDA's concern on cancer drug?

          MarkJ.Terrill/APAmidthestunningrebukeAmgensufferedatthehandsoftheU.S.FoodandDrugAdministrationthiswe

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          VC firm General Catalyst wants to buy a health system

          AdobeVenturefirms,convincedthey’rejumpstartingtheworld’smosthelpfultechproducts,havestruggledmightil